Data Analyst | Power BI Developer | Data Scientist
Hey everyone, I'm Sidney. With over a decade in lab operations and clinical analytics, I build reproducible, stakeholder-ready solutions that bridge technical depth with human relevance.
My portfolio explores predictive modeling, survival analysis, and disease trajectories across breast, prostate, and colon cancer, FSGS kidney disease, bipolar disorder, schizophrenia, and autism spectrum development. I work hands-on with Python, AWS, SHAP, LIME, Tableau, Power BI, and Looker Studio—delivering cloud-based ETL pipelines, interpretable models, and visual storytelling with version control and transparency.
Some of this research is still ongoing, and every project reflects a commitment to clarity, ethics, and actionable insight—because healthcare data deserves nothing less.
This project applies machine learning and clinical data science to model survival outcomes in breast cancer patients. Using predictive algorithms, SHAP/LIME interpretability, it uncovers key risk factors, stratifies patient profiles, and delivers stakeholder-ready visualizations to support precision oncology and early intervention.
This project will explore Focal Segmental Glomerulosclerosis (FSGS) through a clinical data science lens—leveraging predictive modeling, SHAP/LIME interpretability and visualize disease progression. The goal is to deliver actionable insights for nephrology stakeholders while maintaining privacy safeguards and visual clarity across all outputs.
This project will explore Focal Segmental Glomerulosclerosis (FSGS) through a clinical data science lens—leveraging predictive modeling, SHAP/LIME interpretability and visualize disease progression. The goal is to deliver actionable insights for nephrology stakeholders while maintaining privacy safeguards and visual clarity across all outputs.
This project will apply clinical data science to model survival outcomes in colon cancer patients. Using predictive algorithms, SHAP/LIME interpretability, it will uncover key risk factors, stratify patient subtypes, and deliver stakeholder-ready visualizations to support precision oncology and early intervention strategies.